In conclusion, we identified a total of 68 plasma proteins with causal associations to RA, and after multiple testing and analyses, six proteins (FCRL3, SUGP1, TNFAIP3, EHBP1, HAPLN4, and CILP2) were recognized as having the highest potential as drug targets. This evidence concerns the gene HAPLN4 and rheumatoid arthritis.